Preferred Label : Machado-joseph disease;
Symbol : MJD;
CISMeF acronym : MJD; SCA3;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : SCA3; Azorean neurologic disease; Spinopontine atrophy; Spinocerebellar atrophy III; Spinocerebellar ataxia 3; Nigrospinodentatal degeneration;
Description : Machado-Joseph disease, named for affected families of Azorean extraction, is an autosomal
dominant progressive neurologic disorder characterized principally by ataxia, spasticity,
and ocular movement abnormalities. Although independently described as a seemingly
separate disorder, spinocerebellar ataxia-3 is now known to be the same as Machado-Joseph
disease. Three classic clinical subtypes of MJD are recognized: type 1 with early
onset and marked pyramidal and dystonic signs; type 2, or pure, with predominant cerebellar
ataxia; and type 3 with later-onset and peripheral neuropathy (Franca et al., 2008).;
Inheritance : Autosomal dominant;
Molecular basis : Caused by trinucleotide repeat expansion (CAG)n in the ataxin-3 gene (MJD, 607047.0001);
Prefixed ID : #109150;
Origin ID : 109150;
UMLS CUI : C0024408;
Automatic exact mappings (from CISMeF team)
Currated CISMeF NLP mapping
DO Cross reference
False automatic mappings
Genes related to phenotype
HPO term(s)
ORDO concept(s)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to BTNT